URI(s)
Variants
- Staal, Flossie Wong-
- Wong, Yee Ching, 1946-2020
Identifies LC/NAF RWO
Identifies RWO
Birth Date
- 1946-08-27
Death Date
- 2020-07-08
Has Affiliation
- Affiliation Start: 1973
- Affiliation End: 1990
- Organization: National Cancer Institute (U.S.)
Has Affiliation
- Organization: University of California, Los Angeles
Has Affiliation
- Organization: University of California, San Diego
Has Affiliation
- Organization: Immusol
Birth Place
- Guangzhou (China)
Associated Language
- English
Field of Activity
(lcsh) HIV infections--Gene therapy
(lcsh) Hepatitis C--Treatment
Occupation
Exact Matching Concepts from Other Schemes
Closely Matching Concepts from Other Schemes
Sources
- found: The Control of human retrovirus expression, c1988:CIP t.p. (Flossie Wong-Staal, National Cancer Institute)
- found: Retrovirus biology and human disease, c1989:CIP (Flossie Wang-Staal; b. 8/27/46)
- found: Washington post WWW site, viewed July 15, 2020(in obituary dated July 13, 2020: Flossie Wong-Staal, a molecular virologist who led research that helped produce seminal findings about HIV died July 8 in San Diego, Calif. She was 73. Dr. Wong-Staal came to the United States as a university student and joined the National Cancer Institute, a division of the National Institutes of Health in Bethesda, Md., in 1973 as a postdoctoral fellow in the laboratory led by virologist Robert C. Gallo. Over the next 17 years, she became a section chief in the laboratory of tumor cell biology. Yee Ching Wong was born in Guangzhou, China, on Aug. 27, 1946. The family moved to Hong Kong, where Dr. Wong-Staal attended a school run by English-speaking nuns. Dr. Wong-Staal changed her first name on the suggestion of the nuns at her school. She came to the United States to attend the University of California at Los Angeles, where she received a bachelor's degree in bacteriology in 1968 and a doctorate in molecular biology in 1972. After a postdoctoral fellowship at the University of California at San Diego, she joined Gallo's lab, where, in addition to her work on HIV/AIDS, she contributed to research on cancer-causing oncogenes. In 1990, Dr. Wong-Staal left NIH and returned to UC-San Diego, where she led the Center for AIDS Research and investigated approaches to gene therapy as a treatment for HIV/AIDS. She later became co-founder, chief scientific officer and vice president of Immusol, a pharmaceutical company now known as iTherX, where she pursued treatments for hepatitis C. She retired in 2017. Her marriage to Stephen Staal ended in divorce)
Instance Of
Scheme Membership(s)
Collection Membership(s)
Change Notes
- 1988-04-04: new
- 2020-07-15: revised
Alternate Formats
